MARKET WIRE NEWS
  1. Home
  2. Stock
  3. CLDX
  4. News
CLDX
Quote
Short
News
Articles
Message Board

Celldex Therapeutics Inc. (NASDAQ : CLDX ) News

Celldex Therapeutics Inc. (NASDAQ: CLDX) News Releases

CLDX News Releases
CLDX : NASDAQ
GlobeNewswire
Celldex Presents Positive Data Demonstrating Barzolvolimab Retreatment Achieves Similar Profound Efficacy to First Exposure in Patients with Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Further Demonstrating First-in-Class and Best-in-Disease
CLDX : NASDAQ
GlobeNewswire
Celldex Presents Additional Positive Data from Phase 2 Chronic Spontaneous Urticaria (CSU) and Phase 2 Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Studies Further Demonstrating First-in-Class and Best-in-Disease Barzolvolimab Profile at AAAA
CLDX : NASDAQ
US Earnings Reports
Expected US Company Earnings on Thursday, February 26th, 2026
CLDX : NASDAQ
SeekingAlpha
Celldex GAAP EPS of -$1.22 misses by $0.20, revenue of $0.12M misses by $1.34M
CLDX : NASDAQ
GlobeNewswire
Celldex Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
CLDX : NASDAQ
SeekingAlpha
Celldex surges after completing enrollments in late-stage trials for lead asset
CLDX : NASDAQ
GlobeNewswire
Celldex Completes Enrollment in Global Phase 3 Studies (EMBARQ-CSU1 and EMBARQ-CSU2) of Barzolvolimab in Chronic Spontaneous Urticaria
CLDX : NASDAQ
GlobeNewswire
Celldex Announces Multiple Upcoming Presentations at AAAAI 2026 Supporting Barzolvolimab's First-in-Class and Best-in-Disease Profile
CLDX : NASDAQ
SeekingAlpha
MoneyShow's Best Investment Ideas For 2026: Part 3
CLDX : NASDAQ
GlobeNewswire
Celldex Initiates Global Registrational Phase 3 Program of Barzolvolimab in Cold Urticaria and Symptomatic Dermographism

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.